MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/01.tp.0000230373.82376.46

Медицинская библиотека · Transplantation · 2006

Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

Uderzo Cornelio, Bonanomi Sonia, Busca Alessandro, Renoldi Mila, Ferrari Pierantonio, Iacobelli Massimo, Morreale Giuseppe, Lanino Edoardo, Annaloro Claudio, Volpe Aldo Della, Alessandrino Paolo, Longoni Daniela, Locatelli Franco, Sangalli Haidi, Rovelli Attilio

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Thrombotic microangiopathy (TMA) has been described as severe complication after hematopoietic stem cell transplantation (HSCT). The principal aim of this study was to focus the incidence and the outcome of TMA in the era of more complex HSCTs.

METHODS

We analyzed the role of some predicting factors for the incidence and the outcome of TMA after HSCT. We enrolled 539 consecutive patients (307 males, median age 31 years) undergoing HSCT from match or mismatch human leukocyte antigen family donor (314) or match/mismatch unrelated (195) and haploidentical donor (30) for malignant or nonmalignant diseases. TMA diagnosis was performed by homogeneous clinical and laboratory criteria.

RESULTS

Sixty-four of 539 patients presented TMA (11,87%) and the five-year cumulative incidence of TMA was 14% (HR=0.13). Fifty nine of 64 patients were affected by malignant and 5/64 by non-malignant diseases. On multivariate analysis, TMA occurrence was influenced by graft versus host disease >grade II (P=0.0001), donor type (P=0.029), gender (P=0.0233), total body irradiation based conditioning regimen (P=0.0041). Three factors for TMA outcome proved to be statistically significant by multivariate analysis: age (P=0.009), donor type (P=0.0187) and TMA index (P=0.029). The TMA mortality rate was 50%. The outcome was influenced by defibrotide (P=0.02 in univariate analysis).

CONCLUSIONS

The study underlines the possibility of finding out which patients are more prone to developing post-HSCT TMA, and identifies which risk factors are more frequently associated with a dismal outcome after TMA.

Для цитирования: Uderzo Cornelio, Bonanomi Sonia, Busca Alessandro, Renoldi Mila, Ferrari Pierantonio, Iacobelli Massimo, Morreale Giuseppe, Lanino Edoardo, Annaloro Claudio, Volpe Aldo Della, Alessandrino Paolo, Longoni Daniela, Locatelli Franco, Sangalli Haidi, Rovelli Attilio. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.. Transplantation. 2006. DOI: 10.1097/01.tp.0000230373.82376.46.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.